Terms: = Gastric cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
11 results:
1. Expression and clinical value of cxcr4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract] [Full Text] [Related]
2. Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer.
Wei C; Ma Y; Wang F; Chen Y; Liao Y; Zhao B; Zhao Q; Tang D
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15561-15572. PubMed ID: 37648811
[TBL] [Abstract] [Full Text] [Related]
3. Exploring a shared genetic signature and immune infiltration between spontaneous intracerebral hemorrhage and Helicobacter pylori infection.
Liu X; Li M; Han Q; Zuo Z; Wang Q; Su D; Fan M; Chen T
Microb Pathog; 2023 May; 178():106067. PubMed ID: 36914055
[TBL] [Abstract] [Full Text] [Related]
4. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
Xu L; Cai Y; Chen X; Zhu Y; Cai J
BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
[TBL] [Abstract] [Full Text] [Related]
5. Identification and Validation of the Immune Regulator cxcr4 as a Novel Promising Target for gastric cancer.
Xue S; Ma M; Bei S; Li F; Wu C; Li H; Hu Y; Zhang X; Qian Y; Qin Z; Jiang J; Feng L
Front Immunol; 2021; 12():702615. PubMed ID: 34322132
[TBL] [Abstract] [Full Text] [Related]
6. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/cxcr4 axis by regulating autophagy in gastric cancer.
Tang H; Long Q; Zhuang K; Han K; Zhang X; Guo H; Lu X
Pathol Res Pract; 2021 Aug; 224():153532. PubMed ID: 34214844
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of CXCL12/cxcr4 axis as a potential targeted therapy of advanced gastric carcinoma.
Xue LJ; Mao XB; Ren LL; Chu XY
Cancer Med; 2017 Jun; 6(6):1424-1436. PubMed ID: 28544785
[TBL] [Abstract] [Full Text] [Related]
8. VEGFR-3 and cxcr4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Thomaidis T; Maderer A; Al-Batran SE; Kany J; Pauligk C; Steinmetz K; Schad A; Hofheinz R; Schmalenberg H; Homann N; Galle PR; Moehler M
BMC Cancer; 2014 Jul; 14():476. PubMed ID: 24981311
[TBL] [Abstract] [Full Text] [Related]
9. The prognosis and clinicopathology of cxcr4 in gastric cancer patients: a meta-analysis.
Han M; Lv S; Zhang Y; Yi R; Huang B; Fu H; Bian R; Li X
Tumour Biol; 2014 May; 35(5):4589-97. PubMed ID: 24464926
[TBL] [Abstract] [Full Text] [Related]
10. RhoE promotes metastasis in gastric cancer through a mechanism dependent on enhanced expression of cxcr4.
Feng B; Li K; Zhong H; Ren G; Wang H; Shang Y; Bai M; Liang J; Wang X; Fan D
PLoS One; 2013; 8(11):e81709. PubMed ID: 24312338
[TBL] [Abstract] [Full Text] [Related]
11. [Ways to personalized medicine for gastric cancer].
Röcken C
Pathologe; 2013 Sep; 34(5):403-12. PubMed ID: 23907566
[TBL] [Abstract] [Full Text] [Related]
